<bill session="110" type="s" number="3396" updated="2009-01-09T18:58:44-05:00">
	<status><introduced date="1217476800" datetime="2008-07-31"/></status>

	<introduced date="1217476800" datetime="2008-07-31"/>
	<titles>
		<title type="short" as="introduced">Independent Drug Education and Outreach Act of 2008</title>
		<title type="official" as="introduced">A bill to amend the Public Health Service Act to provide grants or contracts for prescription drug education and outreach for healthcare providers and their parents.</title>
	</titles>
	<sponsor id="300061"/>
	<cosponsors>
		<cosponsor id="300059" joined="2008-07-31"/>
		<cosponsor id="300038" joined="2008-07-31"/>
		<cosponsor id="412246" joined="2008-07-31"/>
	</cosponsors>
	<actions>
		<action date="1217476800" datetime="2008-07-31"><text>Sponsor introductory remarks on measure. (CR S7952)</text></action>
		<action date="1217476800" datetime="2008-07-31"><text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	7/31/2008--Introduced.<br/>Independent Drug Education and Outreach Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to award grants or contracts for: (1) the development and production of educational materials concerning the evidence available on the relative safety, effectiveness, and cost of prescription drugs, nonprescription drugs, and nondrug interventions for treating selected conditions, to be distributed and presented to health care providers who prescribe such drugs and their patients; and (2) the development and implementation of a program to appropriately train and deploy health professionals to distribute such materials to, and otherwise educate, physicians and other drug prescribers concerning such drugs and interventions. Requires that grantees receive no support from any entity that manufactures products used to treat the medical conditions discussed.<br/>
	</summary>
</bill>
